Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:EC 3.5.2.6 (beta-lactamase) inhibitor
go back to main search page
Accession:CHEBI:35625 term browser browse the term
Definition:An EC 3.5.2.* (non-peptide cyclic amide C-N hydrolase) inhibitor that interferes with the action of beta-lactamase (EC 3.5.2.6).
Synonyms:related_synonym: EC 3.5.2.6 (beta-lactamase) inhibitors;   EC 3.5.2.6 inhibitor;   EC 3.5.2.6 inhibitors;   ampicillinase inhibitor;   ampicillinase inhibitors;   beta-lactam hydrolase inhibitor;   beta-lactam hydrolase inhibitors;   beta-lactamase A, B, C inhibitor;   beta-lactamase A, B, C inhibitors;   beta-lactamase AME I inhibitor;   beta-lactamase AME I inhibitors;   beta-lactamase I-III inhibitor;   beta-lactamase I-III inhibitors;   beta-lactamase inhibitor;   beta-lactamase inhibitors;   cephalosporin-beta-lactamase inhibitor;   cephalosporin-beta-lactamase inhibitors;   cephalosporinase inhibitor;   cephalosporinase inhibitors;   exopenicillinase inhibitor;   exopenicillinase inhibitors;   neutrapen inhibitor;   neutrapen inhibitors;   penicillin amido-beta-lactamhydrolase inhibitor;   penicillin amido-beta-lactamhydrolase inhibitors;   penicillin beta-lactamase inhibitor;   penicillin beta-lactamase inhibitors;   penicillinase I, II inhibitor;   penicillinase I, II inhibitors;   penicillinase inhibitor;   penicillinase inhibitors



show annotations for term's descendants           Sort by:
 
Augmentin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB11 ATP binding cassette subfamily B member 11 decreases expression EXP Amoxicillin-Potassium Clavulanate Combination results in decreased expression of ABCB11 mRNA CTD PMID:34767876 NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
JBrowse link
G AKR1B10 aldo-keto reductase family 1 member B10 increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of AKR1B10 mRNA CTD PMID:34767876 NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412
JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of CXCL8 protein CTD PMID:11390425 NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
JBrowse link
G CYP27A1 cytochrome P450 family 27 subfamily A member 1 decreases expression EXP Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP27A1 mRNA CTD PMID:34767876 NCBI chr 2:218,782,147...218,815,293
Ensembl chr 2:218,781,749...218,815,293
JBrowse link
G CYP7A1 cytochrome P450 family 7 subfamily A member 1 decreases expression EXP Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP7A1 mRNA CTD PMID:34767876 NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
JBrowse link
G CYP8B1 cytochrome P450 family 8 subfamily B member 1 decreases expression EXP Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP8B1 mRNA CTD PMID:34767876 NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898
JBrowse link
G FGF19 fibroblast growth factor 19 increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of FGF19 mRNA CTD PMID:34767876 NCBI chr11:69,698,238...69,704,022
Ensembl chr11:69,698,238...69,704,022
JBrowse link
G G6PD glucose-6-phosphate dehydrogenase increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of G6PD mRNA CTD PMID:34767876 NCBI chr  X:154,531,390...154,547,569
Ensembl chr  X:154,517,825...154,547,572
JBrowse link
G GCLC glutamate-cysteine ligase catalytic subunit increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of GCLC mRNA CTD PMID:34767876 NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
JBrowse link
G GCLM glutamate-cysteine ligase modifier subunit increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of GCLM mRNA CTD PMID:34767876 NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
JBrowse link
G GGT1 gamma-glutamyltransferase 1 increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of GGT1 protein CTD PMID:34767876 NCBI chr22:24,583,750...24,628,996
Ensembl chr22:24,594,811...24,629,005
JBrowse link
G GPX2 glutathione peroxidase 2 increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of GPX2 mRNA CTD PMID:34767876 NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746
JBrowse link
G GSR glutathione-disulfide reductase increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of GSR mRNA CTD PMID:34767876 NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
JBrowse link
G ME1 malic enzyme 1 increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of ME1 mRNA CTD PMID:34767876 NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051
JBrowse link
G NR0B2 nuclear receptor subfamily 0 group B member 2 increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of NR0B2 mRNA CTD PMID:34767876 NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
JBrowse link
G SLC10A1 solute carrier family 10 member 1 decreases expression EXP Amoxicillin-Potassium Clavulanate Combination results in decreased expression of SLC10A1 mRNA CTD PMID:34767876 NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241
JBrowse link
G SLC51A solute carrier family 51 subunit alpha decreases expression EXP Amoxicillin-Potassium Clavulanate Combination results in decreased expression of SLC51A mRNA CTD PMID:34767876 NCBI chr 3:196,216,534...196,233,427
Ensembl chr 3:196,211,487...196,243,178
JBrowse link
G SLC7A11 solute carrier family 7 member 11 increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of SLC7A11 mRNA CTD PMID:34767876 NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
JBrowse link
G TKT transketolase increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of TKT mRNA CTD PMID:34767876 NCBI chr 3:53,224,712...53,256,022
Ensembl chr 3:53,224,712...53,256,052
JBrowse link
G TXNRD1 thioredoxin reductase 1 increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of TXNRD1 mRNA CTD PMID:34767876 NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
JBrowse link
ceftriaxone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACE2 angiotensin converting enzyme 2 decreases expression ISO Ceftriaxone results in decreased expression of ACE2 mRNA CTD PMID:29745864 NCBI chr  X:15,518,197...15,607,211
Ensembl chr  X:15,494,566...15,607,236
JBrowse link
G ACTB actin beta increases expression ISO Ceftriaxone results in increased expression of ACTB mRNA CTD PMID:29745864 NCBI chr 7:5,527,148...5,530,601
Ensembl chr 7:5,526,409...5,563,902
JBrowse link
G BACE1 beta-secretase 1 decreases expression ISO Ceftriaxone results in decreased expression of BACE1 mRNA CTD PMID:29745864 NCBI chr11:117,285,698...117,316,256
Ensembl chr11:117,285,232...117,316,259
JBrowse link
G CAT catalase decreases expression
multiple interactions
ISO Ceftriaxone results in decreased expression of CAT protein
Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of CAT protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of CAT protein]]
CTD PMID:19442074 PMID:25053526 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
JBrowse link
G DHFR dihydrofolate reductase decreases activity EXP Ceftriaxone results in decreased activity of DHFR protein CTD PMID:25418905 NCBI chr 5:80,626,226...80,654,983
Ensembl chr 5:80,626,226...80,654,983
JBrowse link
G ECE1 endothelin converting enzyme 1 increases expression ISO Ceftriaxone results in increased expression of ECE1 mRNA CTD PMID:29745864 NCBI chr 1:21,217,250...21,345,504
Ensembl chr 1:21,217,247...21,345,572
JBrowse link
G EPO erythropoietin increases expression ISO Ceftriaxone results in increased expression of EPO mRNA CTD PMID:29745864 NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700
JBrowse link
G IDE insulin degrading enzyme increases expression ISO Ceftriaxone results in increased expression of IDE mRNA CTD PMID:29745864 NCBI chr10:92,451,684...92,574,093
Ensembl chr10:92,451,684...92,574,096
JBrowse link
G IL1B interleukin 1 beta multiple interactions ISO Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein]] CTD PMID:25053526 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
JBrowse link
G MME membrane metalloendopeptidase increases expression ISO Ceftriaxone results in increased expression of MME mRNA CTD PMID:29745864 NCBI chr 3:155,024,202...155,183,729
Ensembl chr 3:155,024,124...155,183,704
JBrowse link
G SLC1A2 solute carrier family 1 member 2 multiple interactions
increases expression
ISO Ceftriaxone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of SLC1A2 protein]; Ceftriaxone inhibits the reaction [Cocaine results in decreased expression of SLC1A2 protein]; Ceftriaxone inhibits the reaction [JZL195 results in decreased expression of and affects the folding of SLC1A2 protein]; Ceftriaxone promotes the reaction [Kainic Acid results in increased expression of SLC1A2 protein]
Ceftriaxone results in increased expression of SLC1A2 protein
CTD PMID:19625514 PMID:19717140 PMID:28257918 PMID:29045497 PMID:29432698 NCBI chr11:35,251,205...35,420,507
Ensembl chr11:35,251,205...35,420,063
JBrowse link
G SLC7A11 solute carrier family 7 member 11 multiple interactions ISO Ceftriaxone inhibits the reaction [Cocaine results in decreased expression of SLC7A11 protein] CTD PMID:19717140 NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
JBrowse link
G TNF tumor necrosis factor multiple interactions ISO Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNF protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNF protein]] CTD PMID:25053526 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
clavulanic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB11 ATP binding cassette subfamily B member 11 decreases expression
multiple interactions
EXP Clavulanic Acid results in decreased expression of ABCB11 mRNA
Clavulanic Acid inhibits the reaction [GW 4064 results in increased expression of ABCB11 mRNA]
CTD PMID:34767876 NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
JBrowse link
G ABCB4 ATP binding cassette subfamily B member 4 decreases expression EXP Clavulanic Acid results in decreased expression of ABCB4 mRNA CTD PMID:34767876 NCBI chr 7:87,365,896...87,476,027
Ensembl chr 7:87,401,696...87,480,435
JBrowse link
G ABCC2 ATP binding cassette subfamily C member 2 increases expression EXP Clavulanic Acid results in increased expression of ABCC2 mRNA CTD PMID:34767876 NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
JBrowse link
G ABCG5 ATP binding cassette subfamily G member 5 multiple interactions
decreases expression
EXP Clavulanic Acid inhibits the reaction [GW 4064 results in increased expression of ABCG5 mRNA]; GW 4064 inhibits the reaction [Clavulanic Acid results in decreased expression of ABCG5 mRNA] CTD PMID:34767876 NCBI chr 2:43,806,211...43,839,231
Ensembl chr 2:43,812,472...43,838,865
JBrowse link
G ADH1A alcohol dehydrogenase 1A (class I), alpha polypeptide multiple interactions
decreases expression
EXP Clavulanic Acid inhibits the reaction [GW 4064 results in increased expression of ADH1A mRNA]; GW 4064 inhibits the reaction [Clavulanic Acid results in decreased expression of ADH1A mRNA] CTD PMID:34767876 NCBI chr 4:99,276,369...99,290,985
Ensembl chr 4:99,276,369...99,291,003
JBrowse link
G AKR1B10 aldo-keto reductase family 1 member B10 increases expression EXP Clavulanic Acid results in increased expression of AKR1B10 mRNA CTD PMID:34767876 NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412
JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 decreases expression
increases expression
EXP Clavulanic Acid results in decreased expression of CXCL8 mRNA
Clavulanic Acid results in increased expression of CXCL8 mRNA
CTD PMID:32816093 NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
JBrowse link
G CYP27A1 cytochrome P450 family 27 subfamily A member 1 decreases expression EXP Clavulanic Acid results in decreased expression of CYP27A1 mRNA CTD PMID:34767876 NCBI chr 2:218,782,147...218,815,293
Ensembl chr 2:218,781,749...218,815,293
JBrowse link
G CYP7A1 cytochrome P450 family 7 subfamily A member 1 decreases expression EXP Clavulanic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:34767876 NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
JBrowse link
G CYP8B1 cytochrome P450 family 8 subfamily B member 1 decreases expression EXP Clavulanic Acid results in decreased expression of CYP8B1 mRNA CTD PMID:34767876 NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898
JBrowse link
G EREG epiregulin decreases expression
increases expression
EXP Clavulanic Acid results in decreased expression of EREG mRNA
Clavulanic Acid results in increased expression of EREG mRNA
CTD PMID:32816093 NCBI chr 4:74,365,145...74,388,749
Ensembl chr 4:74,365,145...74,388,749
JBrowse link
G FGF19 fibroblast growth factor 19 increases expression EXP Clavulanic Acid results in increased expression of FGF19 mRNA CTD PMID:34767876 NCBI chr11:69,698,238...69,704,022
Ensembl chr11:69,698,238...69,704,022
JBrowse link
G G6PD glucose-6-phosphate dehydrogenase increases expression EXP Clavulanic Acid results in increased expression of G6PD mRNA CTD PMID:34767876 NCBI chr  X:154,531,390...154,547,569
Ensembl chr  X:154,517,825...154,547,572
JBrowse link
G GCLC glutamate-cysteine ligase catalytic subunit increases expression EXP Clavulanic Acid results in increased expression of GCLC mRNA CTD PMID:34767876 NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
JBrowse link
G GCLM glutamate-cysteine ligase modifier subunit increases expression EXP Clavulanic Acid results in increased expression of GCLM mRNA CTD PMID:34767876 NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
JBrowse link
G GPX2 glutathione peroxidase 2 increases expression EXP Clavulanic Acid results in increased expression of GPX2 mRNA CTD PMID:34767876 NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746
JBrowse link
G GSR glutathione-disulfide reductase increases expression EXP Clavulanic Acid results in increased expression of GSR mRNA CTD PMID:34767876 NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
JBrowse link
G IL1A interleukin 1 alpha increases expression EXP Clavulanic Acid results in increased expression of IL1A mRNA CTD PMID:32816093 NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
JBrowse link
G IL1B interleukin 1 beta increases expression EXP Clavulanic Acid results in increased expression of IL1B mRNA CTD PMID:32816093 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
JBrowse link
G IL24 interleukin 24 increases expression
decreases expression
EXP Clavulanic Acid results in increased expression of IL24 mRNA
Clavulanic Acid results in decreased expression of IL24 mRNA
CTD PMID:32816093 NCBI chr 1:206,897,443...206,904,139
Ensembl chr 1:206,897,443...206,904,139
JBrowse link
G LSS lanosterol synthase decreases expression EXP Clavulanic Acid results in decreased expression of LSS mRNA CTD PMID:34767876 NCBI chr21:46,188,446...46,228,774
Ensembl chr21:46,188,141...46,228,824
JBrowse link
G ME1 malic enzyme 1 increases expression EXP Clavulanic Acid results in increased expression of ME1 mRNA CTD PMID:34767876 NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051
JBrowse link
G MET MET proto-oncogene, receptor tyrosine kinase increases expression EXP Clavulanic Acid results in increased expression of MET mRNA CTD PMID:32816093 NCBI chr 7:116,672,196...116,798,377
Ensembl chr 7:116,672,196...116,798,377
JBrowse link
G MVK mevalonate kinase decreases expression EXP Clavulanic Acid results in decreased expression of MVK mRNA CTD PMID:34767876 NCBI chr12:109,573,272...109,598,125
Ensembl chr12:109,573,255...109,598,125
JBrowse link
G NR0B2 nuclear receptor subfamily 0 group B member 2 increases expression EXP Clavulanic Acid results in increased expression of NR0B2 mRNA CTD PMID:34767876 NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
JBrowse link
G SCD stearoyl-CoA desaturase decreases expression EXP Clavulanic Acid results in decreased expression of SCD mRNA CTD PMID:34767876 NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826
JBrowse link
G SLC10A1 solute carrier family 10 member 1 decreases expression EXP Clavulanic Acid results in decreased expression of SLC10A1 mRNA CTD PMID:34767876 NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241
JBrowse link
G SLC51A solute carrier family 51 subunit alpha decreases expression
multiple interactions
EXP Clavulanic Acid results in decreased expression of SLC51A mRNA
Clavulanic Acid inhibits the reaction [GW 4064 results in increased expression of SLC51A mRNA]
CTD PMID:34767876 NCBI chr 3:196,216,534...196,233,427
Ensembl chr 3:196,211,487...196,243,178
JBrowse link
G SLC7A11 solute carrier family 7 member 11 increases expression
decreases expression
EXP Clavulanic Acid results in increased expression of SLC7A11 mRNA
Clavulanic Acid results in decreased expression of SLC7A11 mRNA
CTD PMID:32816093 PMID:34767876 NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
JBrowse link
G SLPI secretory leukocyte peptidase inhibitor increases expression EXP Clavulanic Acid results in increased expression of SLPI mRNA CTD PMID:32816093 NCBI chr20:45,252,239...45,254,564
Ensembl chr20:45,252,239...45,254,564
JBrowse link
G SREBF1 sterol regulatory element binding transcription factor 1 decreases expression EXP Clavulanic Acid results in decreased expression of SREBF1 mRNA CTD PMID:34767876 NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
JBrowse link
G TKT transketolase increases expression EXP Clavulanic Acid results in increased expression of TKT mRNA CTD PMID:34767876 NCBI chr 3:53,224,712...53,256,022
Ensembl chr 3:53,224,712...53,256,052
JBrowse link
G TNFAIP6 TNF alpha induced protein 6 increases expression EXP Clavulanic Acid results in increased expression of TNFAIP6 mRNA CTD PMID:32816093 NCBI chr 2:151,357,592...151,381,340
Ensembl chr 2:151,357,592...151,380,046
JBrowse link
G TXNRD1 thioredoxin reductase 1 increases expression EXP Clavulanic Acid results in increased expression of TXNRD1 mRNA CTD PMID:34767876 NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
JBrowse link
salsalate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G IL6 interleukin 6 affects expression ISO salicylsalicylic acid affects the expression of IL6 protein CTD PMID:20876710 NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
JBrowse link
G NOS3 nitric oxide synthase 3 multiple interactions ISO salicylsalicylic acid affects the expression of and affects the phosphorylation of NOS3 protein CTD PMID:20876710 NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit affects expression ISO salicylsalicylic acid affects the expression of RELA protein CTD PMID:20876710 NCBI chr11:65,653,601...65,662,916
Ensembl chr11:65,653,599...65,663,090
JBrowse link
G SOD2 superoxide dismutase 2 affects expression ISO salicylsalicylic acid affects the expression of SOD2 protein CTD PMID:20876710 NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
JBrowse link
G VEGFA vascular endothelial growth factor A affects expression ISO salicylsalicylic acid affects the expression of VEGFA protein CTD PMID:20876710 NCBI chr 6:43,770,209...43,786,487
Ensembl chr 6:43,770,184...43,786,487
JBrowse link
tazobactam term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G IL1B interleukin 1 beta multiple interactions ISO Ozone promotes the reaction [[tazobactam co-treated with Piperacillin] results in increased expression of IL1B mRNA] CTD PMID:16369182 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
JBrowse link
G TNF tumor necrosis factor multiple interactions ISO Ozone promotes the reaction [[tazobactam co-treated with Piperacillin] results in increased expression of TNF mRNA] CTD PMID:16369182 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 25553
    role 25490
      biological role 25465
        biochemical role 24717
          enzyme inhibitor 21613
            EC 3.* (hydrolase) inhibitor 20804
              EC 3.5.* (hydrolases acting on non-peptide C-N bonds) inhibitor 20390
                EC 3.5.2.* (non-peptide cyclic amide C-N hydrolase) inhibitor 51
                  EC 3.5.2.6 (beta-lactamase) inhibitor 51
                    3-carboxyphenyl phenylacetamidomethylphosphonate 0
                    7,8-dihydroxy-1-methoxy-3-methyl-10-oxo-1H,10H-pyrano[4,3-b]chromene-9-carboxylic acid 0
                    7,8-dihydroxy-1-methoxy-3-methyl-10-oxo-4,10-dihydro-1H,3H-pyrano[4,3-b]chromene-9-carboxylic acid 0
                    7,8-dihydroxy-3-methyl-10-oxo-10H-chromeno[3,2-c]pyridine-9-carboxylic acid 0
                    avibactam 0
                    avibactam sodium + 0
                    ceftriaxone 13
                    clavulanic acid 34
                    potassium clavulanate + 20
                    salsalate 5
                    tazobactam 2
                    tazobactam sodium + 0
paths to the root